Table 3.
Comparing COVID-19-positive vs COVID-19-negative patients in group C
| Variable | COVID-19 positive (n = 34) | COVID-19 negative (n = 242) | p value |
|---|---|---|---|
| Age, years, mean (SD) | 85.0 (7.7) | 80.8 (11.5) | 0.043 |
| Gender %, M:F | 41.2:58.8 | 36.5:63.5 | 0.598 |
| ASA, n (%) | |||
| 1 | 0 | 4 (1.7) | 0.449 |
| 2 | 6 (17.7) | 67 (27.7) | 0.209 |
| 3 | 18 (52.9) | 122 (50.4) | 0.800 |
| 4 | 10 (29.4) | 48 (19.8) | 0.182 |
| 5 | 1 (2.9) | 0 | 0.707 |
| CCI, mean (SD) | 5.4 (1.4) | 5.2 (2.2) | 0.355 |
| NHFS, mean (SD) | 5.8 (1.5) | 4.8 (1.7) | 0.001 |
| Time to surgery, h, mean (SD) | 54.8 (60.1) | 42.1 (29.2) | 0.423 |
| Length of stay, days, mean (SD) | 17.6 (8.9) | 14.7 (10.8) | 0.014 |
| Mortality, n (%) | 13 (38.2) | 14 (5.8) | < 0.001 |
SD standard deviation, ASA American Society for Anaesthesiology, M male, F female, CCI Charlson Comorbidity Index, NHFS Nottingham Hip Fracture Score